Market News — Wednesday, February 11, 2026
News highlights with AI-explained potential impact from our daily market analysis.
Moderna’s Flu Vaccine Suffers FDA Setback
The FDA refused to review Moderna's mRNA flu vaccine mainly due to design details, not safety or efficacy. This sent the stock down sharply, highlighting inherent biotech sector risks.
Potential Impact: Short-term pain for MRNA investors, but still potential if international reviews succeed. Long-term medical innovation investors should remain patient and diversified.
Royal Caribbean Raises Dividend by 50%
A major cruise operator boosting its dividend reflects confidence in its business recovery and cash generation after years of disruption.
Potential Impact: Income investors benefit, and it may signal improving fundamentals across the travel/leisure sector.
US Retail Sales Miss Expectations—Costco, Walmart Shares Drop
Despite their sizes, even retail powerhouses are not immune to consumer fatigue. Declining sales and store closures point to ongoing pressure in the sector.
Potential Impact: Be cautious with consumer cyclicals and retail; focus on companies with strong balance sheets and essential products.
Cincinnati Financial Surges on Robust Results
Strong earnings, record book value, and well-executed pricing signal operational excellence.
Potential Impact: A potentially attractive holding for conservative, value-focused investors seeking stability and reliable growth.
Amazon’s AWS Spending Seen as Stock Driver
Cloud infrastructure investments continue to power Amazon’s future growth.
Potential Impact: Long-term tech investors may consider adding or holding AMZN shares for ongoing compound growth.
Boeing Faces Multifront Scrutiny
Safety and labor issues highlight operational and reputational risks at a major industrial player.
Potential Impact: Caution warranted; resolution of issues could offer recovery upside, but risk remains elevated.